News: $TRVN Trevena to Report Fourth Quarter and Full Year 2018 Results on March 13, 2019
CHESTERBROOK, Pa., March 04, 2019 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN) , a biopharmaceutical company focused on the development and commercialization of new and innovative treatment options for patients in pain, today announced that it will release its financial results for the...